316 related articles for article (PubMed ID: 33917078)
1. Tumor Signature Analysis Implicates Hereditary Cancer Genes in Endometrial Cancer Development.
Kondrashova O; Shamsani J; O'Mara TA; Newell F; McCart Reed AE; Lakhani SR; Kirk J; Pearson JV; Waddell N; Spurdle AB
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33917078
[TBL] [Abstract][Full Text] [Related]
2. Germline mismatch repair gene variants analyzed by universal sequencing in Japanese cancer patients.
Kiyozumi Y; Matsubayashi H; Horiuchi Y; Higashigawa S; Oishi T; Abe M; Ohnami S; Urakami K; Nagashima T; Kusuhara M; Miyake H; Yamaguchi K
Cancer Med; 2019 Sep; 8(12):5534-5543. PubMed ID: 31386297
[TBL] [Abstract][Full Text] [Related]
3. Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.
Timmerman S; Van Rompuy AS; Van Gorp T; Vanden Bempt I; Brems H; Van Nieuwenhuysen E; Han SN; Neven P; Victoor J; Laenen A; Vergote I
Gynecol Oncol; 2020 Apr; 157(1):245-251. PubMed ID: 31980219
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
[TBL] [Abstract][Full Text] [Related]
5. Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast Cancer.
Li N; McInerny S; Zethoven M; Cheasley D; Lim BWX; Rowley SM; Devereux L; Grewal N; Ahmadloo S; Byrne D; Lee JEA; Li J; Fox SB; John T; Antill Y; Gorringe KL; James PA; Campbell IG
J Natl Cancer Inst; 2019 Dec; 111(12):1332-1338. PubMed ID: 30949688
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of familial endometrial carcinoma: a manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome?
Ollikainen M; Abdel-Rahman WM; Moisio AL; Lindroos A; Kariola R; Järvelä I; Pöyhönen M; Butzow R; Peltomäki P
J Clin Oncol; 2005 Jul; 23(21):4609-16. PubMed ID: 15837969
[TBL] [Abstract][Full Text] [Related]
7. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
[TBL] [Abstract][Full Text] [Related]
8. Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.
Vargas-Parra GM; González-Acosta M; Thompson BA; Gómez C; Fernández A; Dámaso E; Pons T; Morak M; Del Valle J; Iglesias S; Velasco À; Solanes A; Sanjuan X; Padilla N; de la Cruz X; Valencia A; Holinski-Feder E; Brunet J; Feliubadaló L; Lázaro C; Navarro M; Pineda M; Capellá G
Int J Cancer; 2017 Oct; 141(7):1365-1380. PubMed ID: 28577310
[TBL] [Abstract][Full Text] [Related]
9. Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.
Buckley AR; Ideker T; Carter H; Harismendy O; Schork NJ
Genome Med; 2018 Sep; 10(1):69. PubMed ID: 30217226
[TBL] [Abstract][Full Text] [Related]
10. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
[TBL] [Abstract][Full Text] [Related]
11. Familial pancreatic cancer with PALB2 and NBN pathogenic variants: a case report.
Abe K; Ueki A; Urakawa Y; Kitago M; Yoshihama T; Nanki Y; Kitagawa Y; Aoki D; Kosaki K; Hirasawa A
Hered Cancer Clin Pract; 2021 Jan; 19(1):5. PubMed ID: 33413558
[TBL] [Abstract][Full Text] [Related]
12. MUTYH and the mismatch repair system: partners in crime?
Niessen RC; Sijmons RH; Ou J; Olthof SG; Osinga J; Ligtenberg MJ; Hogervorst FB; Weiss MM; Tops CM; Hes FJ; de Bock GH; Buys CH; Kleibeuker JH; Hofstra RM
Hum Genet; 2006 Mar; 119(1-2):206-11. PubMed ID: 16408224
[TBL] [Abstract][Full Text] [Related]
13. Homologous recombination pathway gene variants identified by tumor-only sequencing assays in lung carcinoma patients.
Yoon JY; Roth JJ; Rushton CA; Morrissette JJD; Nathanson KL; Cohen RB; Rosenbaum JN
Transl Lung Cancer Res; 2023 Jun; 12(6):1236-1244. PubMed ID: 37425424
[TBL] [Abstract][Full Text] [Related]
14. Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis.
Alter BP; Best AF
Breast Cancer Res Treat; 2020 Jul; 182(2):465-476. PubMed ID: 32488392
[TBL] [Abstract][Full Text] [Related]
15. Lynch syndrome identification in a Brazilian cohort of endometrial cancer screened by a universal approach.
Rosa RCA; Santis JO; Teixeira LA; Molfetta GA; Dos Santos JTT; Ribeiro VDS; Chahud F; Ribeiro-Silva A; Brunaldi MO; Silva WA; Ferraz VEF
Gynecol Oncol; 2020 Oct; 159(1):229-238. PubMed ID: 32694065
[TBL] [Abstract][Full Text] [Related]
16. Spectrum and Prevalence of Pathogenic Variants in Ovarian Cancer Susceptibility Genes in a Group of 333 Patients.
Koczkowska M; Krawczynska N; Stukan M; Kuzniacka A; Brozek I; Sniadecki M; Debniak J; Wydra D; Biernat W; Kozlowski P; Limon J; Wasag B; Ratajska M
Cancers (Basel); 2018 Nov; 10(11):. PubMed ID: 30441849
[TBL] [Abstract][Full Text] [Related]
17. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects.
Li N; Zethoven M; McInerny S; Devereux L; Huang YK; Thio N; Cheasley D; Gutiérrez-Enríquez S; Moles-Fernández A; Diez O; Nguyen-Dumont T; Southey MC; Hopper JL; Simard J; Dumont M; Soucy P; Meindl A; Schmutzler R; Schmidt MK; Adank MA; Andrulis IL; Hahnen E; Engel C; Lesueur F; Girard E; Neuhausen SL; Ziv E; Allen J; Easton DF; Scott RJ; Gorringe KL; James PA; Campbell IG
NPJ Breast Cancer; 2021 May; 7(1):52. PubMed ID: 33980861
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
Weitzel JN; Neuhausen SL; Adamson A; Tao S; Ricker C; Maoz A; Rosenblatt M; Nehoray B; Sand S; Steele L; Unzeitig G; Feldman N; Blanco AM; Hu D; Huntsman S; Castillo D; Haiman C; Slavin T; Ziv E
Cancer; 2019 Aug; 125(16):2829-2836. PubMed ID: 31206626
[TBL] [Abstract][Full Text] [Related]
20. Risk and prognostic factors for endometrial carcinoma after diagnosis of breast or Lynch-associated cancers-A population-based analysis.
Johnatty SE; Stewart CJR; Smith D; Buchanan D; Leung Y; Oehler MK; Brand A; Webb PM; Spurdle AB
Cancer Med; 2018 Dec; 7(12):6411-6422. PubMed ID: 30485707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]